Evaluate KURA stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in KURA? | Glauxie AI

Q: What are the risks of investing in KURA?

Kura Oncology, Inc. (KURA) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Troy Edward Wilson. Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product... Employees: 260.

Q: How much debt does KURA have?

Review KURA total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is KURA a good long-term investment?

Evaluate KURA as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in KURA?

🦉

Kura Oncology, Inc. (KURA)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOTroy Edward Wilson

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of...

Key Executives

Name	Title
Brian T. Powl	Chief Commercial Officer
Francis J. Burrows	Chief Scientific Officer
Greg Mann	Senior Vice President of Investor Relations & Corporate Affairs
Kathleen Ford	Chief Operating Officer
Mollie Leoni	Chief Medical Officer
Roger Bakale	Senior Vice President of Manufacturing & Supply Chain

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

KURA Profile Financials

Is KURA stock safe? How much debt does KURA have? Is KURA a good long-term investment?